DIS3: The Enigmatic Gene in Multiple Myeloma

Yasuyo Ohguchi1, Hiroto Ohguchi1

  • 1Division of Disease Epigenetics, Institute of Resource Development and Analysis, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-0811, Japan.

Insights

DIS3 mutations and deletions are common in multiple myeloma (MM). Reduced DIS3 activity may drive MM by impairing RNA homeostasis and increasing genome instability.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Next-generation sequencing identifies genetic aberrations in cancer, including multiple myeloma (MM).
  • DIS3 mutations occur in ~10% of MM patients, and chromosome 13 deletions including DIS3 occur in ~40% of MM patients.
  • The role of DIS3 alterations in MM pathogenesis remains unclear.

Purpose of the Study:

  • To summarize the molecular and physiological functions of DIS3.
  • To discuss the potential roles of DIS3 mutations in the development of MM.
  • To explore the link between DIS3 function, RNA homeostasis, and hematopoiesis in MM.

Main Methods:

  • Literature review of studies on DIS3 function and its role in cancer.
  • Analysis of genetic data from multiple myeloma patients.
  • Synthesis of findings on RNA homeostasis and genome stability.

Main Results:

  • DIS3 is crucial for maintaining RNA homeostasis and normal hematopoiesis.
  • Reduced DIS3 activity is implicated in myelomagenesis.
  • DIS3 alterations may contribute to MM by increasing genome instability.

Conclusions:

  • DIS3 plays essential roles in normal hematopoiesis and RNA regulation.
  • DIS3 mutations and deletions are significant in MM pathogenesis.
  • Impaired DIS3 function could be a driver of multiple myeloma development.